Skip to content

Lab Angelus

2 viewers · 30d

Total raised

$350K

+$350K this year

1 filing since 2026 · latest SAFE filed

Cumulative raised
LAST ROUND
SAFE · $350K
ROUNDS
1
INVESTORS
1
FOUNDED
2023
HQ
Merriam, KS
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Lab Angelus is a Kansas City-area healthcare technology company building the coordination layer for precision oncology. Its platform connects community pathology practices, molecular reference laboratories, and treating oncologists so cancer specimens and molecular test results move through one traceable digital workflow instead of faxes, phone calls, and separate lab portals. Its flagship product, LabDispatch, is in commercial deployment with a publicly traded molecular diagnostics partner and is distributed through the Independent Pathology Practice Network.

What sets it apart

Compliance-first architecture — Anti-Kickback Statute Personal Services Safe Harbor, HIPAA, and SOC 2 designed in from the first line of code — combined with existing relationships into the Independent Pathology Practice Network and the academic GOAL consortium, giving it access to both the source and destination labs it connects.

Funding history

1 round
SAFE+1Aug 1, 2026
Form D
+$350K$350K total

Latest SEC filings

via EDGAR · CIK 0002149014
Form D · Aug 1, 2026NewView on EDGAR

Products

1 tracked

LabDispatch

Healthcare workflow platform

A digital coordination and specimen-logistics platform that connects community pathology laboratories to the national molecular reference laboratories performing genomic cancer testing, tracking each request from draft through dispatch, transit, receipt, and result.

  • End-to-end request tracking: drafts, requested, dispatched, in-transit, received, resulted, returned, archived
  • HL7 FHIR resources for orders, specimens, and reports
  • Integrations with the EHR and laboratory information systems community practices already run
  • HIPAA Business Associate framework and SOC 2 controls